Many studies have shown that E2F5 is a oncogene in cancer development, such as breast cancer [44], ovarian cancer [45], hepatocellular carcinoma [46], esophageal squamous cell carcinoma [47] and prostate cancer [48]. Here, E2F5 is linked to breast carcinoma.